ALNY
Alnylam Pharmaceuticals, Inc.
$466.07
0.47%
+2.19
Notify me if price changes either direction
Buy ALNY stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
60.9B
Enterprise value
60.8B
Trailing PE
-213.79816513761
Forward PE
-380.32785
PEG Ratio
-0.73141477547079
Enterprise to EBITDA
-491.731
Enterprise to revenue
24.704
Price to book MRQ
242.55096
Price to sales TTM
24.75205
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-06-30
Revenue (TTM)
2.5B
EBITDA
-123687000
Diluted EPS TTM
-2.46
Total Cash (MRQ)
2.9B
Current ratio (MRQ)
2.801
Operating Cash Flow (TTM)
-15539000
ALNY trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
October 2025
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
